Table 3.
Group F (n=40) | Group P (n=40) | p | ||
---|---|---|---|---|
30 mins postoperatively | Sore throat | 0 (0–1) | 0 (0–2) | 0.026 |
Dysphagia | 0 (0–1) | 0 (0–2) | 0.02 | |
Hoarseness | 0 (0–2) | 0 (0–2) | ns | |
4 h postoperatively | Sore throat | 0 (0–2) | 0 (0–1) | ns |
Dysphagia | 0 (0–0) | 1 (0–1) | 0.04 | |
Hoarseness | 0 (0–1) | 0 (0–1) | ns | |
12 h postoperatively | Sore throat | 0 (0–1) | 0 (0–1) | ns |
Dysphagia | 0 (0–1) | 0 (0–1) | ns | |
Hoarseness | 0 (0–0) | 1 (0–1) | 0.04 | |
24 h postoperatively | Sore throat | 0 (0–2) | 0 (0–1) | ns |
Dysphagia | 0 (0–1) | 0 (0–2) | ns | |
Hoarseness | 0 (0–0) | 0 (0–1) | ns |
Data are shown as median (range)
Abbreviations: Group F: flurbiprofen, Group P: placebo, ns: not significant